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Vitamin E-Stabilised UHMWPE for Orthopaedic Implants:  
Quantitative Determination of vitamin E and Characterisation of  
its Transformation Products  
 
K. Doudin, S. Al-Malaika* 
Polymer Processing and Performance Research Unit, School of Engineering and Applied Science, Aston 
University, Aston Triangle, Birmingham B4 7ET, UK 
 
ABSTRACT 
The fate of vitamin E and the formation and identification of its transformation products were investigated at 
different stages of the manufacturing process of commercially produced cross-linked (by γ-irradiation) UHMWPE 
stabilised with vitamin E (vitamin E infused-post irradiation) used for tibia-components (as articulating surfaces) in 
total knee arthroplasty (total knee replacement). Vitamin E (α-tocopherol) and its transformation products were 
extracted from microtomed Tibia films and the different products were separated, isolated, purified using high 
performance liquid chromatography (HPLC), and characterised by spectroscopic methods and LC-MS. The 
amount of vitamin E and that of the products formed in the different Tibia samples and in their extracts were also 
quantified using FTIR and HPLC analysis and calibration curves. Thorough analysis of the Tibia extracts has 
shown that a number of vitamin E transformation products were formed at different concentrations at two selected 
stages of the implant manufacturing process that is before and after sterilisation by γ-irradiation. The identified 
products were found to correspond mainly to different stereoisomeric forms of a small number of vitamin E 
transformation products. Most of the observed products were of dimeric and trimeric nature with their identity 
confirmed through a detailed study of their spectral and chromatographic characteristics. It was found that the 
products of vitamin E, prior to the sterilisation step but after the crosslinking and doping of vitamin E, were mainly 
the dihydroxydimers and trimers (Tibia samples at this stage are referred to as “Tibia-VEPE”).   After sterilisation 
and completion of the manufacturing process, additional dimers of vitamin E were also formed (Tibia samples at 
this stage are referred to as ‘Tibia-VEPE-Sterile’), Furthermore, two tocopherol-derived aldehydes (aldehyde 5-
formyl-γ-tocopherol and aldehyde 7-formyl-γ-tocopherol) were also formed but at very low concentrations 
especially in the Tibia-VEPE-Sterile samples. The question of whether vitamin E becomes chemically reacted 
(grafted) onto the polymer matrix during the manufacturing process of the Tibia is also addressed. 
Keywords: vitamin E; Orthopaedic implants; UHMWPE; antioxidant 
--------------------------------------------------------------------------------------------- 
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1. Introduction 
Highly crosslinked medical grade UHMWPE has been widely used as acetabular cup and Tibia component in total 
hip and knee arthroplasty (total joint replacements, TJR) [1], and the crosslinked polymer has replaced the initially 
used conventional (not crosslinked) UHMWPE due to significant improvements in wear resistance, a critically 
important property in prosthetic applications involving joints, leading to reduction in osteolysis [2, 3]. Crosslinking 
of UHMWPE is typically achieved through the use of gamma irradiation [4] resulting in formation of free radicals in 
the amorphous phase of the polymer and their subsequent recombination, though some of the generated free 
radicals become trapped mostly in the crystalline phase [5, 6]. The residual free radicals result in oxidative 
instability of the polymer, thus a number of approaches have been introduced to reduce the adverse effect of 
these free radicals produced during the γ-irradiation/crosslinking process. Thermal treatment after irradiation (by 
melting or annealing) has been used to decrease the concentration of the residual free radicals and to minimize or 
eliminate their adverse effects on the properties of UHMWPE [7-10]. The post-irradiation melting approach 
releases the trapped free-radicals from the crystalline regions allowing them to recombine forming further cross-
links; but this method was shown to also result in reduction in the mechanical properties and fatigue strength of 
the irradiated UHMWPE due to decrease in the polymer crystallinity [11]. The annealing process (below the 
polymer peak melting point) was also shown to [12, 13] result in reduction in the free radical concentration with 
further recombination. Furthermore, the final step of gamma irradiation (at lower dose) which is used for 
sterilisation of the polymer implant components result in the introduction of additional free radicals in the system 
[14] contributing further to the oxidative instability of the polymer.  
To combat this problem and to promote long-term oxidative stability of UHMWPE and longevity of the implants, 
vitamin E has been successfully used as an effective biocompatible antioxidant for this purpose. Initially, Vitamin 
E was introduced by blending into the UHMWPE resin powder before consolidation and radiation crosslinking [15-
18], but the presence of this highly efficient free radical scavenger antioxidant during the irradiation process 
resulted in reduction in the crosslinking efficiency as well as in a partial consumption of vitamin E itself. The 
amount of vitamin E that could be incorporated into the polymer by this method was found to be limited to 
approximately 0.3 wt. % [19]. Optimisation of both the added vitamin E concentration and the subsequent 
radiation dose were therefore examined by different authors [15-19]. Research has led to development of a 
different method of introduction of vitamin E into the polymer in which the antioxidant vitamin is diffused into the 
UHMWPE after the radiation crosslinking step [2, 14]. The crosslinking efficiency of UHMWPE was shown not to 
be adversely affected by this approach due to the absence of vitamin E during the γ-irradiation/crosslinking step. 
The diffused antioxidant vitamin removes the trapped free radicals due to its well-known high radical-scavenging 
efficiency, and this method was shown also to give rise to higher concentrations of vitamin E in the polymer of up 
to about 0.7 wt % [14, 20]. 
The reactions of vitamin E during melt processing of polymers and particularly polyolefins were extensively 
investigated in our laboratories since the 1990’s and the chemical nature and distribution of oxidative 
transformation products formed from dl-α-tocopherol (Vitamin E) in processed polyolefins were identified and 
characterised [21-25]. The extracts of vitamin E stabilised polymers reported from these studies revealed 
formation of a large number of products but some were attributed to different stereoisomeric forms of the same 
products. Most of the products formed during melt processing of Vitamin E-stabilised polyethylene and 
polypropylene were based on dimers and trimers of α-tocopherol, as well as quinones and aldehydes [21-25]. 
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 To our knowledge, there is no published work on the fate of vitamin E, or, the formation and nature of any of its 
transformation products that may form in UHMWPE orthopaedic implant components (manufactured by Vitamin E 
antioxidant infused technology) during the various stages of their production; both after the initial high γ-irradiation 
dose (typically 100 kGy) used for crosslinking (Tibia samples at this stage are referred to here as ‘Tibia-VEPE’) 
and after the second lower dose gamma irradiation (typically 25-40 kGy) used for sterilization (Tibia samples at 
this stage are referred to as ‘Tibia-VEPE-Sterile’). Some literature findings have made the assumption, based on 
hexane reflux extraction at 70oC, that vitamin E becomes chemically bonded (grafted) onto the polymer [26, 27], 
this assumption will be addressed here.  
In this study, UHMWPE-Tibia samples produced for Total Knee Arthroplasty were used in order to investigate the 
fate of vitamin E and the nature of its transformation products (extracted from microtomed Tibia samples) formed 
at two stages of the implant manufacturing process before and after sterilisation (Tibia-VEPE and Tibia-VEPE-
Sterile). The amount of vitamin E was quantified and its transformation products in the different Tibia samples 
were isolated, quantified and characterised. A fresh Vitamin E solution, vitamin E solution retrieved from the 
implants doping process and fresh vitamin E samples that were γ-irradiated were also analysed in order to 
understand the reaction products formed at the different stages of the Tibia manufacturing process.  
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UHMWPE compression moulded into 
1. The bars machined into preforms 
(kidney shape) 
2. Packaged under argon (Ar)  
3. γ-irradiated at ~100 kGy 
9. Sterilisation; γ-irradiation at ~25 kGy 
‘Tibia-VEPE-Sterile’ 
(Final product) 
  
Crosslinked polymer preforms  
4. Unpackaged 
5. Doped in Vitamin E (122oC) 
6. Annealed/homogenised-N2 (130oC) 
7. Machined to final shape 
8. Re-packaged under Ar gas 
  
‘Tibia-VEPE’ 
 
2. Experimental 
 
2.1. Materials 
Tibia component samples, UHMWPE resin and vitamin E solutions were kindly donated by Biomet Inc. (Warsaw, 
IN). The UHMWPE resin utilized was medical grade GUR1020 (Ticona, Bishop, TX), vitamin E (dl-α-tocopherol) 
was obtained from Fisher Scientific, Houston, TX. All other solvents used were HPLC (Fisher) and NMR grades 
(deuterated chloroform, Goss Scientific) and were used without further purification.  
2.2. Sample Preparations 
The manufacturing process of the Tibia samples is described briefly in Scheme 1. Isostactically compression 
moulded UHMWPE (GUR 1020) bar stocks produced at Biomet Inc. were machined into kidney shape preforms. 
The preforms were packaged under argon gas and the packages were γ-irradiated to crosslink the polymer at a 
dose of 100 kGy. The irradiated samples were then doped by immersion in a bath containing vitamin E at 122ºC 
under continuous stirring for 5 hours (vitamin E infusion) in order to diffuse through the thickness of the polymer 
samples and were subsequently annealed at about 130ºC under continuous nitrogen flow for at least three days 
for homogenization. The samples were then machined into Tibia shapes (Tibia-VEPE) and packaged under 
argon gas. The packaged Tibia samples were sterilized (with lower dose of γ-irradiation of 25 k Gy, ‘Tibia-VEPE-
Sterile’), see Scheme 1, [19, 28-31]. 
 
Scheme 1. Schematic diagram for the production of vitamin E diffusion-post irradiation process of Tibia samples (the Tibia 
photograph is curtesy of Biomet Inc)  
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The Tibia samples were microtomed into thin films (100 µm thicknesses) using a rotary microtome (Leica 
RM2165). Vitamin E and the various transformation products were extracted from the microtomed films by two 
methods; reflux in boiling hexane or by accelerated solvent extraction (ASE). For extraction by reflux in hexane, 
2g microtomed films were refluxed under nitrogen atmosphere in 100 ml HPLC grade hexane for 24 hrs followed 
by cooling and evaporation of the solvent in a fume cupboard. Accelerated Solvent Extraction (ASE) method was 
conducted in a Dionex ASE200 with hexane or with 5% cyclohexane in dichloromethane at different temperatures 
(ranging from 70ºC to 122ºC); 2g microtomed films were used and all samples were extracted for 5 cycles, each 
cycle was 15 min with a pressure of 2000 psi. The extracts were transferred into a beaker and left to dry in a fume 
cupboard before use. 
2.3. Evaluation of the Amount of Vitamin E and the Oxidative Induction Time in Microtomed Tibia Films 
In order to evaluate the amount of vitamin E in Tibia film samples (microtomed at ~ 100 µm), two defined vitamin 
E indices were determined and were measured as a function of depth by line scanning using a Fourier Transform 
Infrared microscope (FTIR; Perkin Elmer spectrum GX AutoIMAGE FTIR-Microscope). Spectra were obtained in 
transmission mode over the range 4000-700 cm-1 using 16 scans and resolution of 4 cm-1 and the line scans were 
collected from the films across the width of each section (through two edges of the samples spanning two 
opposite free surfaces) in 100 µm intervals. The concentrations of vitamin E, and vitamin E and transformation 
products, in the films were quantified by calculating vitamin E indices defined as the ratio of the absorption area 
under a specific vitamin E peak (at 1263 cm-1 (1275 to 1245 cm-1) [6, 28] and at 1210 cm-1 (1225 to 1195 cm-1) 
[32] normalised to that of a polyethylene backbone absorbance peak at 1895 cm-1 (1985 to 1850 cm-1). 
 
A Mettler Toledo Differential Scannining Calorimeter (DSC model 832e) interfaced with a PC was used to 
measure the Oxidative Induction Times (OIT) of Tibia films (100 µm) before and after extraction according to 
ASTM-D3895-03. 2-5 mg microtomed film samples (done in triplicates) were placed in open DSC pans and 
heated from 40oC to 190oC at a rate of 25oC/min under nitrogen flow. The samples were held at 190°C for 5 min 
and then the nitrogen was switched over to oxygen keeping the same gas flow rate (40 ml/min). The oxidation 
induction time was obtained as the time between the onset of the oxygen gas flow and the intersection of the 
isothermal base line with the tangent at 1 mW deviation from the isothermal baseline. 
2.4. Quantification of Vitamin E and its Transformation Products from Tibia Extracts 
 
Vitamin E and its transformation products were extracted from different Tibia components and quantified using an 
analytical HPLC method developed for this purpose. The HPLC analysis was performed on a Thermo Scientific 
UltiMate 3000 HPLC system equipped with vacuum degasser, quaternary pump, an autosampler and a UV/Vis 
diode array detector. The chromatographic separation of extracts of microtomed Tibia films was carried out in an 
isocratic mode using a Zorbax-RX-SIL (5µm, 4.6 x 250 mm) analytical column at operating temperature of 30°C, 
constant flow rate of 1 ml/min, UV detection wavelength of 297 nm and with a 25 µl injection volume. The mobile 
phase was pre-mixed 98.0 hexane / 2.0% dioxane. The concentration of the products was determined from their 
HPLC peak area using the method described below.  
A method was developed based on analytical HPLC analysis and calibration curves constructed for vitamin E, 
and for each of the isolated and purified transformation products. The calibration curves were produced from 
HPLC peak areas (analysed using the isocratic conditions described above) plotted against the compound’s 
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known concentrations (expressed in mg/ml hexane) obtained from stock solutions of 1 mg/ml hexane of each of 
the isolated pure products. The Tibia extracts from 2 g microtomed films (extracted on ASE using 
cyclohexane/DCM from 85-122oC or by reflux with hexane) were dried and then dissolved in 10 ml hexane and 
analysed using the analytical HPLC method described above. The peak area for each product and its calibration 
curves were used to calculate the amount of each product (in mg) in the extracts, which was used to calculate the 
concentration of the products in the Tibia based on the amount extracted. Therefore, the amount of transformation 
products formed, and that of vitamin E, were quantified and presented as weight percent of the total amount 
extracted (concentrations were calculated as part per million (ppm) based on weight of the polymer used and the 
amounts of the quantified products). The different vitamin E solutions were analysed by dissolving a 100 mg in 
100 ml hexane (using the same method), the calibration curves were then used to calculate the amount of each 
product and vitamin E in the solutions. Repeat analysis of at least three samples taken from different locations of 
the implants were analysed and the resulting concentration averages of each compound are recorded. 
In spite of this, it is important to point out that caution need to be exercised regarding the absolute accuracy of the 
calculated concentrations, particularly, for some of the products for a number of reasons. If the amount of an 
isolated transformation product was very small then their purity may not have been absolute (although each was 
purified at least twice through the HPLC process). Further, the detection wavelength used in the HPLC analysis 
was fixed at 297 nm rather than using the optimum wavelength for each compound. This, in addition to the fact 
that some of the products, e.g. Dimer-Ox, were not highly stable (though analysis of these compounds was done 
immediately after their collection and with maximum care to ensure minimum error). 
2.5. Separation of Vitamin E Transformation Products 
 
The final sterilised Tibia samples (VEPE-Sterile) were microtomed into 100 µm films, 20 g of the microtomed 
films were placed in 2L round bottom flask with 1L HPLC grade hexane, stirred and refluxed under nitrogen 
atmosphere for 24 hrs followed by drying (in a fume cupboard) and re-dissolving in hexane (HPLC grade) for 
HPLC fractionation. A Thermo Scientific UltiMate 3000 HPLC system was used for semi-preparative and 
preparative work for separation and collection of the different product fractions (the system which was described 
in section 2.3, also comprised of a fraction collector). The normal phase separation was achieved using Zorbax 
RX-SIL columns (7µm, 21.2 x 250 mm for preparative and 5µm, 9.4x250 mm for semi-preparative HPLC) with a 
mobile phase (used in both Prep- and Semi-Prep-HPLC systems) of varying ratios of 1,4-dioxane: hexane (from 
0.5 to 2.0% dioxane in hexane) and UV detection at four different wavelengths in order to ascertain the presence 
of the different products. 
2.6. Spectroscopic Characterisation of the Separated Transformation Products 
The purified transformation products of vitamin E isolated from Tibia samples were characterised by different 
spectroscopic methods; NMR, FTIR and UV-Vis as well as by LC-MS spectroscopy. Proton and carbon nuclear 
magnetic resonance (1H and 13C NMR) spectra were recorded on a Bruker Avance-300 spectrometer at ambient 
temperature using tetramethylsilane (TMS) as internal standard. 1D and 2D NMR spectra were recorded using a 
5 mm normal dual detection probe and operating at controlled temperatures. The NMR samples were prepared by 
dissolving 20 mg of the purified transformation products in 0.7 ml deuterated chloroform (CDCl3) solvent which 
contained 0.05% TMS. For 1H NMR, the spectra were recorded at 300.13 MHz using a high-resolution dual (1H 
13C) gradients probe. Spectra were recorded using the zg30 pulse program with 32 scans and referenced to an 
internal TMS standard at 0.0 ppm. PENDANT 13C NMR spectra were obtained at 75 MHz for carbon. The 
pendant pulse program was used with waltz16 decoupling during acquisition with 2048 scans and phased for 
CH3/CH positive and quaternary carbons and CH2 negative with internal reference TMS at 0.0 ppm. 2-
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Dimensional 1H-13C Heteronuclear Multiple Bond Coherence (HMBC) spectra, which correlate 1H and 13C 
chemical shifts through multiple-bond heteronuclear scalar coupling (nJCH, n = 2 or 3) were also recorded. The 
cross peaks in the 1H-13C HMBC spectra shows the chemical shifts of 1H on one axis (horizontal) which correlated 
to 13C (on the vertical axis) that belongs to H and C atoms which are separated by two or three chemical bonds. 
The 2-Dimensional 1H-13C Heteronuclear Single Quantum Coherence (HSQC) spectra, which correlate 1H and 
13C chemical shifts through single-bond heteronuclear scalar coupling (1JCH) were also recorded. The cross peaks 
in the 1H-13C HMBC spectra shows the chemical shifts of 1H on one axis (horizontal) which correlated to 13C (on 
the vertical axis) that belongs to H and C atoms which are chemically bonded.  
Fourier Transform Infrared (FTIR) measurements were performed on a Perkin Elmer Spectrum One, over the 
range of 4000-400 cm-1; spectral collection was taken over 16 scans with resolution of 4 cm-1. Ultraviolet-visible 
(UV-Vis) spectra of solutions and thin Tibia polymer films were recorded at room temperature on Cary 5000i 
(Agilent) UV-Vis spectrophotometer at a scanning rate of 600 nm/min. The Liquid chromatography-Mass 
Spectroscopy (LC-MS) detection analysis was performed using Thermo MSQ plus instrument coupled to the 
analytical HPLC system (described above) used in negative mode soft ionisation at Atmospheric Pressure 
Chemical Ionization (APCI) mode with cone voltage of 100 V, probe Temperature 500ºC and mass detection 
range of 100–2000 m/z. 
 
3. Results and Discussion 
 
3.1. Characterisation of Vitamin E and its transformation products from Tibia components 
 
The nature of vitamin E transformation products that may have formed in the final Tibia product (Tibia-PEVE-
Sterile), see Scheme 1, was investigated through their characterisation and identification using complementary 
spectroscopic methods followed by quantification of the products. The different transformation products were 
extracted from the Tibia samples and were then separated. 
 
Twelve well separated peaks of vitamin E and its transformation products are observed from the analytical HPLC 
chromatogram, see Figure 1 peaks A to L. These were subsequently isolated and a detailed characterisation of 
each of the isolated products was carried out using different spectroscopic methods as described below (see 
structures in Table 1).  
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Figure 1: HPLC chromatogram of Tibia (Tibia-VEPE-Sterile) extracts using analytical HPLC method 
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Table 1: Structures of vitamin E and its transformation products isolated from Tibia samples along 
with selected spectroscopic characteristics  
COMPOUND 
(code) 
 
 
STRUCTURE 
FTIR main 
peaks 
cm
-1
 
UV λ max  
(nm) 
MS,  
molecular 
ion peaks 
Vitamin E 
 
 
 
 
 
 
C-O-C: 1262 
 
C-O-H: 1212 
 
O-H: 3470  
 
 
297, 289 
 
 
 
 
 
429 
Tocopherol-3-ene 
(Toc-ene) 
 
 
  
  
C=C: 
1600/1550 
 
 C-O-C: 1261 
 
 
 
 
335, 281, 
272 
 
 
 
 
 
427 
Dihydroxydimers 
(DHD) 
 
 
 
 
 
 
 
 
 
C-O-C; 1261  
C-O-H; 1211 
 
 
 
298, 291, 
281 
 
 
 
 
858 
Trimers 
(TRI) 
 
 
 
 
 
 
R
2
2
3
34
4
5
5
5a
5a
6
6 7
7
7a
7a
8
8
8a
8a
9
9
10
1012
12
13
13
14
14
15
15
15a
15a
16
1617
17
17a
17a
18
18
18a
18a
19
19
20
20
22
22
23
23 24
24
25
25
25a
25a
26
26
27
27
27a
27a
28
28
28a
28a
29
29
30
30
 
C=O;1739  
and 1693 
 
 
C-O-C; 1260  
C-O-H; 1208 
 
 
 
 
 
 
 
 
295 
 
 
 
 
 
 
 
 
 
 
1284 - 
1285 
Aldehydes 
(Ald-5 & Ald-7) 
 
 
 
 
O
OH
R
H
O
5
6
         
4
7
6
5
 
 
C=O: 1635  
C-O-C:  1262  
O-H 
 
3467  
 
 
387, 281, 
272 
 
 
 
 
443 
Dimer-Ox 
 
 
 
 
 
 
 
 
 
 
C-O-C:1265  
O-H :3420  
(973 ) 
 
 
292 
 
 
 
 
 
 
858 
 
 
 
 
DHD
3
3*
4
4*
5a
5a*
7a
7a*
8a 8a*
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Fraction A: 
 
The main peak A, eluted at 13 min, was characterised as the parent compound vitamin E. The vitamin (dl α-
Tocopherol) was fully characterised (using 1D NMR; 1H and 13C Pendant, 2D NMR; HSQC and HMBC, FTIR, UV 
and LC-MS) in order to use it as a reference compound to aid with the characterisation of the different 
transformation products. 1H and 13C NMR spectra of vitamin E are shown in Figure 2. The main signals that are 
used here for the purpose of analysis and characterisations of the transformation products are based on the 
groups attached to the phenol and the chroman rings. In the 1H NMR spectra (Figure 2A) there are three CH3 
groups on the phenol ring ; 5a and 7a at 2.14 ppm and 8a at 2.19 ppm, and on the chroman ring there are two 
methylenes (CH2); 3 at 1.80ppm and 4 at 2.63ppm in addition to the CH3 group (2a) at 1.26ppm. The 13C Pendant 
NMR signals are assigned in Figure 2B where the carbons of the rings are labelled as 2 -10 and the carbon for 
the CH3 groups on the phenol ring are labelled 5a, 7a and 8a, in addition to the CH3 group (2a) on the chroman 
ring.   
 
Figure 2C shows the 2D HMBC NMR spectrum of fresh vitamin E, of a special interest here is the correlation 
between the protons on the two methylene groups (CH2: H3 and H4) in the chroman ring and various carbons as 
this is the part of the vitamin molecule where the changes would occur in most of its transformation products. The 
correlation between protons on carbon number 3 (H3) and carbons C4, C2a, C1’, C2 and C10 which are two or 
three bonds away from protons H3 (the green lines) is clearly illustrated, as well as the correlation between the 
protons on carbon number four (H4) and carbons C3, C2, C10, C5 and C9. 
 
The FTIR spectrum of Vitamin E, see Figure 2D and Table 1, shows the presence of two important absorptions at 
1262 cm-1 (ether C-O stretching of the chroman ring) and at 1212 cm-1 (C-O stretching of the phenol hydroxyl 
group) with the former being normally used to quantify the amount of vitamin E in the polymer [32]. In this work, 
both peaks were used to estimate the amounts of vitamin E and the transformation products in the polymer 
samples before extraction [2, 28, 32]. The UV-spectrum of vitamin E shows absorptions at 291 and 297 nm, and 
its MS spectrum (from LC-MS) has given a molecular ion peak with a mass of 429 (Figure 2E) confirming that this 
HPLC peak A is that of vitamin E. 
 
 
Fraction B:  
 
The second HPLC peak B that appeared in the chromatogram after vitamin E at a retention time of 14.0 min (see 
Figure 1) corresponds to a monomer product based on one vitamin E molecule having a molecular ion in its MS 
spectrum with a mass of 427 (Figure 3A). The UV spectrum of this product (Figure 3B) showed three λmax at 272, 
281 and a longer wavelength absorption at 335 nm compared to that of vitamin E which gave absorptions at the 
low wavelengths of 291 and 297 nm only.  
 
The 1H NMR spectrum of this isolated product (see Figure 3C) is very similar to that of vitamin E except for 
protons H3 and H4 appearing at 5.55 and 6.45 ppm with each peak being a doublet suggesting that they are two 
single neighbouring protons (with coupling constants of 10Hz for cis protons) positioned next to a double bond. 
Protons H3 and H4 of vitamin E which appeared at 1.80 and 2.63 ppm (Figure 2A) are completely absent in 
compound B (see Figure 3C). These characteristics suggest that this product is Tocopherol-3-ene (see Table 1 
for Toc-ene structure), which we have not seen in our previous studies on melt processing of polyethylene with 
vitamin E [23]. 
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Figure 2: Spectra of vitamin E: (A) 1H and (B) 13C Pendant NMR; (C) HMBC NMR; (D) FTIR 
spectrum and (E) mass spectra, from LC-MS (from HPLC fraction A) 
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Figure 3: Spectra of Toc-ene obtained from Tibia extracts (HPLC fraction B): (A) Mass spectrum 
(from LC-MS); (B) UV spectrum (compared with that of vitamin E) obtained from Tibia 
extracts (HPLC fraction B); (C) 1H NMR spectrum 
 
Fractions C and D;  
The amount of these products was very small for full isolation and characterisation, but their chromatographic 
retention and UV and MS analyses (not shown here) fit well with the characterisatics of spirodimers of vitamin E 
(SPD) with their full characterisation reported in our previous work [21-25]. 
Fractions E and F:  
Peaks with retention times of 25.7 and 26.8 min (see Figure 1) were found to have very similar NMR, UV and MS 
characteristics with their molecular ion peak appearing at m/s of 858, Figure 4A and B, suggesting a dimeric 
structure. The 1H NMR spectra (Figure 4B) of these compounds show that there are only two types of CH3 
groups on the phenol rings (7a/7a* and 8a/8a*) at 2.13 and 2.07 ppm. The 5a/5a* methylene protons are shifted 
here downfield and apeared at 2.67ppm, and are shown to have a very colse chemical shift to that of the CH2 
groups in the chroman rings 4/4* at 2.69 ppm. The 13C pendant NMR (Figure 4C) confirms the observations in 
the 1H NMR spectrum and shows that one of the CH3 groups in the vitamin E phenol ring (proton 5a, +ve at 10.5 
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ppm, Figure 4C-VE) has been converted to CH2 groups in the product (protons 5a, 5a*, -ve at 25.2 and 28.9 ppm, 
Figure 4C-DHD). The 13C spectrum also shows the shift of C4 from 20 ppm in vitamin E to 19.2 ppm in 
compounds E and F which suggest that the change in the molecular structure has taken place in a position near 
to C4 but not on this carbon. The UV analysis of this product showed similar results to vitamin E with an 
absorption band at λmax of 298 nm. These characterisations, and also based on our earlier literature [23, 25], 
confirm that these two products are sterioisomers of dihydroxydimer (DHD), see Table 1 for structure. 
 
Figure 4: spectra of Dihydroxydimers (HPLC fractions E and F) obtained from Tibia extracts: (A) MS 
(from LC-MS); (B) 1H NMR; (C) 13C pendant NMR spectra compared with that of vitamin E 
 
Fractions G and H; 
 The first few product peaks that eluted in the analytical HPLC analysis between 3.2-5.2 min (Figure 1) were 
collected and re-run on a preparative HPLC to give five separated peaks (one was a mixture of two of the 
isomeric products), see Figure 5A, which were then isolated and fully characterised. The spectral characteristics 
(NMR, UV, MS, FTIR) of each of the four main pure isolated fractions were found to be very similar to those of 
stereoisomers of the same trimeric product of vitamin E that we have reported earlier [23, 24]. For example, the 
1H NMR spectra of the four compounds isolated from the Tibia-VEPE-Sterile extracts shown in Figure 5B clearly 
show similar characteristics except for some minor chemical shift differences for the signals of protons 17a and 
18a. Similarly, their UV spectra were also very similar having one main absorption at λmax of 296 nm. The identity 
of these compounds as trimers is further evidenced from their FTIR spectra (Figure 6A) showing main 
absorptions at 1693 and 1648 corresponding to >C=O and >C=C<, respectively (see TRI structure), and their MS 
(from LC-MS) spectra giving a molecular ion peak corresponding to the Trimers at 1285 and 1284 (3 times molar 
mass of Toc) – 6 H], Figure 6B.  
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Figure 5: (A) Prep HPLC chromatogram of the trimeric products isolated from Tibia extracts; (B) their 1H NMR 
spectra (fractions G and H) 
 However, it is interesting to note that these different sterioisomeric trimers have some slight differences in the 
FTIR of their carbonyl region. For example, the trimer that eluted at 3.6 min (TRI 3) showed a stronger absorption 
in the 1738 cm-1 region compared to that of the trimer that had eluted at 3.3 min (TRI 1) suggesting a slightly 
different environment around the carbonyl group of these two trimers which may be due to two main isomeric 
structures of the trimers, TRI-A and TRI-B, which have been identified in the literature previously [21-25] [33-35]. 
The structure of Trimer-A was identified in our earlier work [24], it has its carbon number 26 bridging through the 
hydroxyl oxygen to carbon number 19 of the second part of the molecule and the carbon of the methyl group (that 
has become methylene group, C 25a) bridges to carbon number 20 of the second molecule. Structure Trimer-B 
was reported in earlier literature [21-25] [33-35], in which carbon number 26 bridges through the hydroxyl oxygen 
to carbon number 20, whereas the methyl group carbon (carbon 25a) bridges to carbon number 19 of the second 
part of the molecule, see structures in Table 1. Each of these two different structures can form a number of 
sterioisomers, hence the presence of several peaks in the HPLC chromatogram that have very similar 
characteristics but all belonging to the trimeric structure. 
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Figure 6: Spectra of Trimeric products isolated from Tibia extracts (HPLC fractions G and H): (A) 
their FTIR spectra and (B) their MS spectra 
Fractions I and L:  
 These two peaks which had retention times of 4.6 and 5.3 min (see Figure 1) were found to each contain an 
extra oxygen atom. The 1H NMR spectrum, Figure 7A, of the compound corresponding to peak L (elution at 5.3 
min) shows clearly the presence of an aldehydic proton (H5’) at 10.1 ppm as well as a phenol proton (H6’) at 12.0 
ppm. The 2D 1H-13C HMBC NMR spectra of compound L, Figure 7B, shows that the two protons are correlated to 
the carbon of the phenol ring (C5 and C6) and also the aldehydic proton (H5’) showed a J1 correlation to the 
aldehyde carbons C5’; two contour plots correlation to the carbon at 193 ppm, confirming the structure as that of 
Tocopherol-5-aldehyde (ALD-5). Further support of this aldehyde structure is clear from its UV spectrum 
showing a long wavelength absorption maximum at 387 nm, see Figure 7C attributed to the presence of an aryl 
aldehyde group. The FTIR spectrum of compound L (Figure 7D and Table 1) shows a distinct carbonly 
absorption (-C=O) at 1635 cm-1 and a (-C-O) stretch absorption at 1311 cm-1 typical of aldehydic carbonyl. The 
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above characterisation, along with the MS results showing a molecular ion peak with m/s of 443, Figure 7C, and 
similarity to literature characteristics [23-25] further confirms the identity of compound L as Tocopherol-5-
aldehyde (ALD-5), see Table 1. 
 
Figure 7: Spectra of Ald-5 isolated from Tibia extract (HPLC fraction L): (A) 1H NMR; (B) HMBC-
NMR; (C) mass spectrum; (D) FTIR spectrum (compared with that of vitamin E) 
 
The NMR of the compound corresponding to peak I (elution time of 4.6 min) also showed both aldehydic and 
phenolic protons that appeared at 10.2 and 11.8 ppm, respectively, very slightly shifted compared to those seen 
in Ald-5, Figure 8A, and a corresponding aldehydic carbon signal in its 13C NMR at 195 ppm (not shown here). 
The UV spectrum of this compound I, Figure 8C showed a λmax at 390 nm quite similar to the 387 nm absorption 
observed in the other aldehyde, Ald-5, these characteristics and the observed molecular ion at m/s of 443, Figure 
8B, confirm the identity of this compound as Tocopherol-7-aldehyde (ALD-7), see Table 1. 
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Figure 8: Spectra of Tocopherol-7-aldehyde (Ald-7) isolated from Tibia extracts (HPLC fraction I): 
(A) 1H NMR spectra (compared with that of Ald-5); (B) MS spectrum; (C) UV-Vis spectra  
Fractions J and K:  
The compound corresponding to peak K which had a retention time of 5.0 min (see Figure 1) was isolated, 
purified and characterised by 1H and 13C NMR. Figure 9A gives the 1H NMR spectra for this fraction (analysed 
immediately after being collected) and shows methylene (CH2) group protons at a chemical shift of 4.87 ppm (H5’) 
and a corresponding carbon (C5’) having 13C NMR shift at 71.7 ppm (Figure 9B). The 1H NMR spectrum also 
shows the presence of five CH3 groups located on aromatic rings (chemical shift between 2.0 and 2.2 ppm which 
are different from each other. It is important to note that this compound has only one –OH group having a 
chemical shift of 7.8 ppm compared to the phenolic –OH of vitamin E which appears at 4 ppm. The sharpness of 
the signal for this proton and its chemical shift suggests that this proton is associated with a close-by atom 
through a uniform hydrogen bonding. 
The 1H NMR spectrum also shows the presence of two types of CH2 groups (see Figure 9, 4 and 4’). The 2D 
HMBC NMR analysis, Figure 9C, of this compound showed correlations between the protons of the CH2 at 4.87 
ppm (H5’) and the aromatic ring carbons C5, C6 and C10. Similarly, the 2D HSQC NMR spectra (Figure 9D) 
show the correlation between the same CH2 group (at 4.87 ppm, H5’) and the carbon at 71.8 ppm (C5’) 
confirming that these protons are directly bonded. 
The UV-vis analysis of this product showed a very similar spectrum to that of vitamin E with a λmax at 292 nm 
compared to 297 nm for vitamin E. The LC-MS analysis of this product gave a mass of 429 which is the same as 
that of vitamin E.  This suggests that the product is not very stable and fragments easily under heating during the 
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MS-analysis into two molecules of vitamin E. Based on all the above characterisation a dimeric structure 
dimerised via a –C-O-C link is suggested for compound K with the structure of a Dimer-Ox shown in Table 1. The 
compound corresponding to peak J was an unstable product which has rearranged rapidly to the DHD during its 
characterisation. 
 
Figure 9: Spectra of dimenr-Ox (HPLC fraction K) extracted from Tibia: (A) 1H NMR; (B) 13C NMR; 
(C) 2D HMBC-NMR; (D) HSQC NMR (all NMR analysis was carried out immediatly after 
disolving the sample in the NMR solvent) 
 
3.2. The Concentration Profile of Vitamin E and Transformation Products as a Function of Depth of the 
Tibia Samples 
The concentration profiles of vitamin E and transformation products were determined across the depth of the Tibia 
polymer samples (both before and after the sterilisation stage) using vitamin E indices determined by micro-FTIR 
line-scanning. Each Tibia sample was first sliced in half and FTIR spectra were collected across the width of 
microtomed thin sections (through the freshly cut face from the centre of the flat face to the top of the sample 
along points X-Y in Figure 10A) in100 µm intervals. Vitamin E index based on the 1263 cm-1 peak [6, 12] which 
corresponds to the aryl-O-alkyl ether group (in the chroman ring) is less accurate as a measure of the vitamin E 
concentration than the 1210 cm-1 peak index [32] which corresponds to the C-O stretch of the phenol ring. This is 
mainly due to the fact that all the transformation products discussed above have at least one chroman ring, thus 
the 1263 cm-1 index would give rise to a measure of the combined amount of vitamin E and all its products in the 
samples as can be seen from Figure11. However, although measurements based on the 1210 cm-1 peak index 
(C-O of the phenol ring) can be considered to be a more accurate assessment of vitamin E concentration in the 
polymer of the Tibia samples, attention should be drawn here to the fact that even for this index, a mild 
interference from some of the products that have a similar phenol C-O absorption (e.g. DHD, Toc-ene, Alds) could 
be expected. However, Figure 11 shows that the IR-absorption peaks of these transformation products at 2010 
cm-1 are very small compared to that of the vitamin peak at 1210 cm-1 and also compared to the products 
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absorption peak at 1263 cm-1, therefore, the 1210 peak index can still be considered a more accurate measure of 
vitamin E concentration in the Tibia polymer. 
Based on the 1263 cm-1 peak index, Figure 10B shows that both Tibia-VEPE and Tibia-VEPE-Sterile samples 
give a similar total concentration profile of vitamin E and its products across the depth of both set of samples. 
However, the 1210 cm-1 index shows clearly that the Tibia-VEPE-Sterile samples have lower amount of vitamin E 
than is the case for Tibia-VEPE samples, see Figure 10C, suggesting that a higher amount of transformation 
products must have formed in the Tibia-VEPE-Sterile samples. These results are in good agreement with the 
quantified amounts of the products collected from the Tibia-VEPE-Sterile extracts, see next section. 
 
Figure 10: Vitamin E depth profiles (based on FTIR indices for peaks 1263 cm-1 and 1210 cm-1) 
for Tibia-VEPE and Tibia-VEPE-Sterile samples 
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Figure 11: FTIR spectra of vitamin E and transformation products showing the two peaks at 1263 cm-1 
and 1210 cm-1 in the spectrum of vitamin E and the appearance of mainly the 1263 cm-1 in 
the transformation products. 
 
3.3. Quantitative Analysis of Vitamin E and its Transformation Products in Tibia Extracts and 
Mechanism of their Formation 
 
In order to have a better understanding of the amount and distribution of the different transformation products 
formed in the Tibia samples at the two selected stages of their manufacture (before and after the sterilisation 
process), the different transformation products were extracted from Tibia-VEPE and Tibia-VEPE-Sterile samples 
and their concentrations quantified using the analytical HPLC method described earlier. Similarly, transformation 
products formed in a vitamin E solution that was retrieved from the doping chamber, and from one that was γ-
irradiated, were also analysed and quantified. 
 
HPLC analysis of the liquid fresh untreated vitamin E sample showed it to be ~99.3% pure and contained only 
about 0.7% of other α-tocopherol isomers, whereas a vitamin E sample that had been γ-irradiated with a dose of 
300 kGy had ~98.7% vitamin E in addition to low concentration of Toc-ene (0.5%) along with the formation of a 
small concentration of DHD (fresh vitamin E does not contain any DHD). Further, analysis of a vitamin E sample 
that was retrieved from the doping chamber of the manufacturing process, showed it to have an even lower 
amount of the vitamin E (~97%) with some concentration of Toc-ene (0.6%) and a higher amount of DHD (2.3%), 
Table 2.  
For the manufactured Tibia samples (Tibia-PEVE and Tibia-PEVE-Sterile), the amount of Vitamin E and that of 
the formed transformation products were analysed, using different extraction methods, quantified and compared. 
An overview of the outcome of the distribution of transformation products and their relative concentrations in each 
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type of the Tibia samples is summarised in Figure 12 and Table 2. Figure 12 shows a comparison of the 
amounts (averages of at least three repeats, from different parts of different batches of any one type of Tibia 
sample, normalised as percent of the total) of vitamin E and each of its main products after extraction by reflux 
with hexane and by ASE with cyclohexane/DCM at 100oC, while Table 2 shows the concentrations as averages 
from ASE extractions at a range of temperatures of 85-122oC (a number of repeats per sample at each 
temperature, results are expressed both as percent of the total extract and by weight in part per million, ppm). 
It is clear from Figure 12 and Table 2, that based on the ASE at 100oC extraction method, the Tibia-VEPE 
samples (before sterilisation) contained an average amount of vitamin E of about 94% with the main products 
formed being the dihydroxydimers (DHD~ 2.2 %), an amount similar to that quantified in the retrieved vitamin E 
solution from the doping chamber, trimers (TRI~ 1.5 w%), the Dimer-Ox (~1.3 w%) along with small amounts of 
Toc-ene and Ald-5 (Ald-7 was not detected). On the other hand, the sterilisation process involved in the final 
stage of the Tibia-VEPE-Sterile production has given rise to a reduction in both the amount of vitamin E (down to 
~84%) and that of the DHD (reduced by about 20% compared to the Tibia-VEPE samples) accompanied by an 
almost 4 fold increase in the concentrations of the TRIs, Dimer-Ox, aldehydes, and formation of a small 
concentration of the spirodimer (not present/ not detectible in Tibia-VEPE samples). 
The consistently lower concentration of DHD (under all extraction conditions and repeat analysis) and the higher 
concentration of Toc-ene formed in the Tibia-VEPE-Sterile samples compared to Tibia-VEPE, see Figure12, 
suggests that the second low dose of γ-irradiation contributes to breaking-down some of the DHD giving rise to 
the generation of Toc-ene and more tocopherol, see Reaction 1. However, the amount of tocopherol (VE) found 
in the Tibia-VEPE-Sterile samples was shown to be lower than that in the Tibia-VEPE, but this can be explained 
by the fact that the γ-irradiation conditions used for sterilisation would almost certainly result in further 
transformations from the tocopherol leading to its reduction and the observed, almost 4-fold, increase in the other 
products formation.  
 
Figure 12. Average amount (normalised as % of total) of VE and its transformation products separated from 
Tibia-VEPE (blue) and Tibia-VEPE-Sterile (red) samples using ASE extraction at 100oC, A, 
(each result is an average of TWO samples tested) and extraction by reflux in hexane, B, (~70ºC) 
for Tibia-VEPE, results are average of FOUR samples and for Tibia-VEPE-Sterile average of 
THREE samples) 
A A 
B B 
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Table 2: Quantification of Vitamin E and transformation products in extracts (ASE, cyclohexane/DCM, 
100oC) of Tibia-VEPE and Tibia- VEPE-Sterile Samples, and in vitamin E solutions γ-
irradiated, and a retrieved sample from the doping chamber of the manufacturing process. 
The results are the total average of 7-8 samples analysed taken from at least 3 or 4 
extractions at temperatures ranging from 85 ºC to 122 ºC at different locations of the Tibia 
samples. 
 
Compounds 
extracted from 
Tibia Samples 
 
 
Tibia-VEPE 
(pre-sterilisation) 
Average (w%) 
 
Tibia-VEPE 
(pre-sterilisation) 
Average (ppm) 
 
Tibia-VEPE-Sterile 
(post-sterilisation) 
Average (w%) 
 
Tibia-VEPE-Sterile 
(post-sterilisation) 
Average (ppm) 
Vitamin E (VE) 94.2 3869 83.8 3130 
Trimers 1.5 60 5.7 212 
Ald-7 ~0 2 0.2 7 
Dimer-Ox 1.3 54 5.3 197 
Ald-5 0.3 13 1.3 49 
Toc-ene 0.5 21 0.7 26 
SPD 0.0 0 1.2 44 
DHD 2.2 89 1.8 70 
TOTAL 100% 4108 100% 3735 
     
 
α-tocopherol 
% 
DHD 
w% 
Toc-ene 
w% 
Unstable Dimers 
w% 
Fresh VE 
(99.3 + 0.7) = 
100 0 
 
0 
 
0 
VE-300 kGy 98.7 0.5 0.5 0.3 
VE-doping 97.1 2.3 0.6 0 
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The much higher amount of Dimer-ox found in the Tibia-VEPE-Sterile samples is almost certainly formed directly 
from tocopherol via coupling of the tocopheroxy radical and tocobenzyl radical, reaction 2.  
 
  
 
Further, the small amount of SPD formed in the Tibia-VEPE-Sterile samples (but not in Tibia-VEPE) accounts for 
the much higher concentration of the TRIs formed in the Tibia-VEPE-Sterile, since the main path to the formation 
of the TRIs is via the SPD, reactions 3 and 4, it is also known that the SPDs are generally less stable under more 
severe conditions [22, 25]. The fact that SPDs are not detected in Tibia-VEPE samples does not necessarily 
mean that they are not formed, almost certainly they are formed but transformed immediately to the TRIs and their 
small concentration (not detected) would be responsible for the formation of the observed much lower 
concentration of the TRIs in the Tibia-VEPE samples (compared to four times higher level in Tibia-VEPE-Sterile 
samples). 
 
We have also shown in our earlier literature [22] that Toc-Alds are generally formed at higher amounts under 
more severe and oxidative conditions. In this case, it is the influence of the second dose of γ-irradiation, though 
γ-irradiation 
H-abstraction 
H-abstraction 
Tocopherol 
Toc-ene 
(1) 
H-abstraction 
H-abstraction 
DHD 
Toc-benzyl radical 
Tocopheroxyl radical 
(2) 
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under a controlled environment with limited amount of oxygen (vacuum packed under Ar), would be responsible 
for the formation of the small concentrations of Ald-5, and even lower amount of Ald-7, observed in the Tibia-
VEPE-Sterile samples. The aldehydes are formed as a consequence of oxidation of the Toc-benzyl radical 
followed by hydrogen abstractions, see reaction 5 for Ald-5 [22]. 
  
 
 
 
 
 
Diels-Alder  
(3a) 
SPD QM TRI 
SPD 
Diels-Alder  
(3b) 
TRI 
QM 
(4) 
ROO•  
SPD Tocopherol TRI 
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3.4. The Question of Graftability and Extraction of Vitamin E from Tibia Samples  
Some earlier literature has claimed that small amount of vitamin E grafts on the UHMWPE during the 
manufacturing process of the Tibia, this conclusion was based on results of extraction of Tibia samples in hexane 
at 70oC [36]. To address the question of whether vitamin E does actually get chemically linked to the Tibia 
polymer during their manufacturing process, we have subjected Tibia samples to different extraction 
methodologies conducted at different temperatures followed by examination of their Oxidative Induction Times 
(OIT) as an indicative measure of the polymer stability due to any remaining unextractable (chemically linked) 
vitamin E. 
Table 3 shows that the OIT of the virgin (unstabilised) UHMWPE polymer (a Bar stock) is, as expected, very low 
(less than a minute), whereas the Tibia-VEPE-Sterile gave ~ 85 min. Extraction in hexane at 70oC and by ASE at 
80oC reduced the OIT down to a quarter of its initial value (to ~20 min) suggesting that some of the stabilisers 
were not completely extracted under these conditions. Therefore, harsher conditions were used in order to check 
if vitamin E could possibly have become grafted during the manufacturing process. Extraction using ASE with 
cyclohexane (5%) in dichloromethane at 110ºC gave rise to complete loss of the OIT in Tibia-VEPE-Sterile 
samples down to less than a minute which is the same as that for a completely unstabilised UHMWPE. These 
findings show clearly that vitamin E and its transformation products are fully extractable and the vitamin does not 
graft onto UHMWPE which is used for making orthopaedic implants by the vitamin E infused manufacturing 
technology.  
 
 
 
 
 
 
 
(5) 
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Table 3: OIT for the Tibia films before and after extraction in ASE with hexane and with a 
solvent mixture (5% cyclohexane in DCM) at different temperatures (5 cycles 
15min each at 2000 psi), each sample was re-extracted for a second time under 
the same conditions; standard deviation is shown in brackets 
Sample/Extraction OIT of Tibia-VEPE-Sterile, 
min.  
virgin UHMWPE 0.5  (±0.2) 
Before extraction 87 (±7) 
Reflux in hexane (70°C) 22  (±1) 
ASE in hexane at 80°C 21 (±1) 
ASE in cyclohexane/DCM at 100°C 11 (±1) 
ASE in cyclohexane/DCM at 105°C 3  (±1) 
ASE in cyclohexane/DCM at 107°C 2  (±1) 
ASE in cyclohexane/DCM at 110°C 0.5  (±0.5) 
 
4. Conclusion 
Different vitamin E transformation products formed during the manufacturing process of crosslinked UHMWPE 
Tibia samples produced by the ‘the vitamin E antioxidant infused technology’ before (Tibia-VEPE) and after (Tibia-
VEPE-Sterile) the sterilisation stages were separated, isolated, purified, identified and quantified. The crosslinked 
(γ-irradiation dose of ~100 kGy) and vitamin E-doped polymer in the Tibia-VEPE samples were found to retain 
about 94% of the vitamin with the formation of mainly different stereoisomers of dihydroxydimers (DHD), trimers 
(TRI), dimer-Ox, and a small amount of Toc-ene and aldehyde-5. The final Tibia product, the Tibia-VEPE-Sterile 
samples (after sterilisation with about 25 kGy), on the other hand, was shown to have a lower amount of vitamin E 
of ~84% and a reduced amount of the DHD, but this was accompanied by an almost a four-fold increase in the 
concentrations of the TRI, dimer-ox, aldehydes and a marginal increase in Toc-ene as well as the formation of 
spirodimer that was not detected in the Tibia-VEPE sample. The latter, is suggested to be, at least in part, 
responsible for the increased amount of the trimers formation, whereas the DHD reduction is also suggested to be 
responsible for the formation of more Toc-ene and regeneration of vitamin E which upon the second dose of γ-
irradiation for sterilisation is further consumed to generate more transformation products, thus the higher overall 
concentration of products in the Tibia-VEPE-Sterile samples, the mechanism of the formation of these products 
was outlined. It was also shown categorically that vitamin E does not chemically graft to UHMWPE during the 
manufacturing process in contrast to some previous literature suggestions. 
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Caption of Figures 
Figure 1:  HPLC chromatogram of Tibia (Tibia-VEPE-Sterile) extracts using analytical HPLC method  
Figure 2:  Spectra of vitamin E: (A) 1H and (B) 13C Pendant NMR; (C) HMBC NMR; (D) FTIR spectrum and 
(E) mass spectra, from LC-MS (from HPLC fraction A) 
Figure 3:  Spectra of Toc-ene obtained from Tibia extracts (HPLC fraction B): (A) Mass spectrum (from LC-
MS); (B) UV spectrum (compared with that of vitamin E) obtained from Tibia extracts (HPLC 
fraction B); (C) 1H NMR spectrum 
Figure 4:  Spectra of Dihydroxydimers (HPLC fractions E and F) obtained from Tibia extracts: (A) MS 
(from LC-MS); (B) 1H NMR; (C) 13C pendant NMR spectra compared with that of vitamin E 
Figure 5:  Preparative HPLC chromatogram of the trimeric products isolated from Tibia extracts (A); their 
1H NMR spectra, fractions G and H (B) 
Figure 6:  Spectra of Trimeric products isolated from Tibia extracts (HPLC fractions G and H): (A) their 
FTIR spectra and (B) their MS spectra 
Figure 7:  Spectra of Ald-5 isolated from Tibia extract (HPLC fraction L): (A) 1H NMR; (B) HMBC-NMR; (C) 
mass spectrum; (D) FTIR spectrum (compared with that of vitamin E) 
Figure 8:  Spectra of Tocopherol-7-aldehyde (Ald-7) isolated from Tibia extracts (HPLC fraction I): (A) 1H 
NMR spectra (compared with that of Ald-5); (B) MS spectrum; (C) UV-Vis spectra  
Figure 9:  Spectra of dimenr-Ox (HPLC fraction K) extracted from Tibia: (A) 1H NMR; (B) 13C NMR; (C) 2D 
HMBC-NMR; (D) HSQC NMR (all NMR analysis was carried out immediatly after disolving the 
sample in the NMR solvent) 
Figure 10:  Vitamin E depth profiles (based on FTIR indices for peaks 1263 cm-1 and 1210 cm-1) for Tibia-
VEPE and Tibia-VEPE-Sterile samples 
Figure 11:  FTIR spectra of vitamin E and transformation products showing the two peaks at 1263 cm-1 and 
1210 cm-1 in the spectrum of vitamin E and the appearance of mainly the 1263 cm-1 in the 
transformation products. 
Figure 12: Average amount (normalised as % of total) of VE and its transformation products separated from 
Tibia-VEPE (blue) and Tibia-VEPE-Sterile (red) samples using ASE extraction at 100oC, A, 
(each result is an average of TWO samples tested) and extraction by reflux in hexane, B, (~70ºC) 
for Tibia-VEPE, results are average of FOUR samples and for Tibia-VEPE-Sterile average of 
THREE samples)   
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Caption of Tables 
 
Table 1:  Structures of vitamin E and its transformation products isolated from Tibia samples along with 
selected spectroscopic characteristics 
 
Table 2: Quantification of Vitamin E and transformation products in extracts (ASE, cyclohexane/DCM, 100 
oC) of Tibia-VEPE and Tibia- VEPE-Sterile Samples, and in vitamin E solutions -irradiated, and a 
retrieved sample from the doping chamber of the manufacturing process. The results are the total 
average of 7-8 samples analysed taken from at least 3 or 4 extractions at temperatures ranging 
from 85ºC to 122ºC at different locations of the Tibia samples. 
Table 3: OIT for the Tibia films before and after extraction in ASE with hexane and with a 
solvent mixture (5% cyclohexane in DCM) at different temperatures (5 cycles 
15min each at 2000 psi), each sample was re-extracted for a second time under 
the same conditions; standard deviation is shown in brackets. 
 
 
 
 
 
 
 
 
 
 
 
